Cargando…

851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality

BACKGROUND: In the US, Staphylococcus aureus Bacteremia (SAB) occurs in about 19.7 /100,000 people. A recent increase in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia infections rate and mortality has led to more infectious diseases (ID) consultations. We assessed if an infectious di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Travez, Robert D, Eagleston, Anjuli, Brandt, Dominique, Blatt, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776014/ http://dx.doi.org/10.1093/ofid/ofaa439.1040

Ejemplares similares

267. Characteristics and Trends of Serratia Blood Stream Infections
por: Elabd, Hatem, et al.
Publicado: (2020)

851. Validation of Quick Pitt Bacteremia Score in Patients with Staphylococcus aureus Bloodstream Infection
por: Elizabeth. Battle, Sarah, et al.
Publicado: (2019)

213. Assessment of Compliance with Order Set and Bundle for Management of Staphylococcus aureus Bacteremia
por: Flynn, Ryan R, et al.
Publicado: (2021)

117. Adjunctive Daptomycin in the Treatment of staphylococcus Aureus Bacteremia
por: Cheng, Matthew P, et al.
Publicado: (2020)

264. Anti-platelet Therapy Significantly Reduces Inpatient Mortality in Patients with Staphylococcus aureus Bacteremia
por: Caffrey, Aisling, et al.
Publicado: (2020)

269. Clinical Characteristics and Outcomes of Persistent Staphylococcus aureus Bacteremia
por: Yang, Eunmi, et al.
Publicado: (2020)

850. External Validation of the Methicillin-Resistant Staphylococcus aureus Bacteremia Score
por: Boyle, Ellen, et al.
Publicado: (2020)

67. Impact of a Pharmacist-Driven Collaborative Initiative on Staphylococcus aureus Bacteremia Management
por: Kufel, Wesley D, et al.
Publicado: (2020)

962. Impact of Care Bundle Element Compliance on Clinical Outcomes for Pediatric Patients with Staphylococcus aureus Bacteremia
por: Pallotta, Raneem, et al.
Publicado: (2023)

266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Mohamed, Adham, et al.
Publicado: (2020)

187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021)

133 Compliance with follow-up cultures in Staphylococcus aureus bacteremia: Opportunity for quality improvement
por: Thomas, Benjamin S., et al.
Publicado: (2014)

1817. Characteristics and Outcomes in Patients with Staphylococcus lugdunensis Bacteremia Compared with Staphylococcus aureus and Staphylococcus epidermidis Bacteremia
por: Yukawa, Satomi, et al.
Publicado: (2022)

311. The Role of Transthoracic Echocardiography in Staphylococcus aureus Bacteremia; A Retrospective Chart Review
por: Aldred, Bruce M, et al.
Publicado: (2020)

227. Staphylococcus aureus bacteremia: back to normal
por: Pedromingo Kus, Miguel Sebastian, et al.
Publicado: (2023)

275. Comparison of Cefazolin versus Nafcillin for Methicillin-Susceptible Staphylococcus aureus Bacteremia with a Deep-Seated Source
por: Mersinger, Katherine E, et al.
Publicado: (2020)

292. Impact of the BACT/ALERT VIRTUO blood culture system in the management of Staphylococcus aureus bacteremia
por: Chavez, Miguel A, et al.
Publicado: (2020)

307. Rapid Resistance Development to Three Antistaphylococcal Therapies in Daptomycin-tolerant Staphylococcus aureus Bacteremia
por: Miller, Christopher R, et al.
Publicado: (2020)

301. Penicillin Versus Cefazolin or Anti-staphylococcal Penicillins for Penicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aldhaeefi, Mohammed, et al.
Publicado: (2020)

302. Peripheral IV catheters, a common source of healthcare-associated Staphylococcus aureus bacteremia
por: Young, Heather, et al.
Publicado: (2020)

190. Outcomes of Early Ceftaroline-based Combination Therapy for Methicillin-resistant Staphylococcus aureus Bacteremia
por: Dolan, Mackenzie, et al.
Publicado: (2021)

216. Bacterial Genotype and Clinical Outcomes in Solid Organ Transplant Recipients with Staphylococcus aureus Bacteremia
por: Eichenberger, Emily, et al.
Publicado: (2021)

282. Epidemiological Evaluation of Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia: A Comprehensive Cancer Center’s 10-Year Experience
por: Ford, Charles R, et al.
Publicado: (2020)

Staphylococcus aureus Bacteremia in Children: The Effect of Methicillin Resistance
por: Hamdy, Rana F, et al.
Publicado: (2017)

1060. Risk Factors for Recurrent Staphylococcus aureus Bacteremia
por: Choi, Seong-Ho, et al.
Publicado: (2018)

97. The Utilization of Echocardiography in Children with Staphylococcus aureus Bacteremia
por: Bui, Richard, et al.
Publicado: (2023)

276. Comparison of Ceftaroline in Combination with Either Vancomycin or Daptomycin for the Treatment of Methicillin-resistant Staphylococcus aureus Bacteremia
por: Welch, Stephanie N, et al.
Publicado: (2020)

263. An Evaluation of Quality Indicators for the Management of Staphylococcus aureus Bacteremia: A Nested Case-Control Study
por: Simms, Andrew, et al.
Publicado: (2020)

280. Description of Transesophageal Echocardiography Prescribing Practices in non-Staphylococcus aureus Bacteremia with Application of Scoring Systems
por: Luttmann, Kelly F, et al.
Publicado: (2020)

257. Staphylococcus aureus Bacteremia: Does Intravenous Drug Use Impact Quality of Care and Clinical Outcomes?
por: McClellan, Kristen, et al.
Publicado: (2020)

291. Impact of Surveillance and Offered Infectious Diseases Consults for Staphylococcus aureus Bacteremia on Quality of Care Indicators
por: Jhaveri, Khushali, et al.
Publicado: (2020)

1373. Racial Disparities in Clinical Characteristics and Outcomes for Methicillin Susceptible and Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Mohnasky, Michael C, et al.
Publicado: (2021)

1227. Development of a Clinical Prediction Model for Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Jorgensen, Sarah, et al.
Publicado: (2018)

Prevention of nosocomial bacteremia associated with Staphylococcus aureus in Benin
por: Ahoyo, TA, et al.
Publicado: (2015)

P851: TARGETING GENE DEPENDENCIES IN MYC OVEREXPRESSING MULTIPLE MYELOMA
por: Hasan Bou Issa, L., et al.
Publicado: (2022)

312. Unplanned Readmission after Hospitalization with Staphylococcus aureus Bacteremia in Children: a Multistate Population Based Study
por: Inagaki, Kengo, et al.
Publicado: (2020)

335. Staphylococcus aureus Bacteremia as a Potential and Severe Complication from Intramuscular COVID-19 Vaccine Injection
por: Kus, Miguel Sebastian Pedromingo
Publicado: (2021)

181. Demographic and Geographic Epidemiology of Staphylococcus aureus Bacteremia using Geographic Information Systems Mapping and Spatial Statistics
por: Marshall, Julia, et al.
Publicado: (2021)

Staphylococcus aureus Bacteremia, Europe
por: Tiemersma, Edine W., et al.
Publicado: (2005)

Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia
por: Gregory, Eric, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9nrqrln5c9le2l5v0hbl4f1f31